| Literature DB >> 31304357 |
Brian Caulfield1,2, Brenda Reginatto2, Patrick Slevin3.
Abstract
Recent years have witnessed an explosion in the number of wearable sensing devices and associated apps that target a wide range of biomedical metrics, from actigraphy to glucose monitoring to lung function. This offers big opportunities for achieving scale in the use of such devices in application contexts such as telehealth, human performance and behaviour research and digitally enabled clinical trials. However, this increased availability and choice of sensors also brings with it a great challenge in optimising the match between the sensor and a specific application context. There is a need for a structured approach to first refining the requirements for a specific application, and then evaluating the available devices against those requirements. In this paper we will outline the main features of such an evaluation framework that has been developed with input from stakeholders in academic, clinical and industry settings.Entities:
Keywords: Outcomes research; Technology
Year: 2019 PMID: 31304357 PMCID: PMC6550243 DOI: 10.1038/s41746-019-0082-4
Source DB: PubMed Journal: NPJ Digit Med ISSN: 2398-6352
Three primary application contexts for human performance devices
| Application | Use cases |
|---|---|
| Wellness/Fitness | Personal health/wellness use cases, where the goal is to use data from the device to help a person to better manage their lifestyle. |
| Fitness and performance use cases, where the goal is to provide data than can help to guide a training programme for sporting activity. | |
| Healthcare | Behaviour modification use cases, where the goal is to provide input to a structured treatment programme for management of a healthcare issue, or engage patients in their own care process. |
| Clinical decision-making process use cases, where the goal is to provide data that can guide diagnosis, treatment decisions or measure outcomes of care. | |
| Clinical trials/Research | Behaviour modification use cases, where the goal is to provide input to a self-directed intervention that might compliment or enhance the impact of a therapeutic product. |
| Endpoints, where the goal is to document the impact of a therapeutic product. |
Example of high-level requirements for deploying a wearable tracker in different application contexts
| Application context | Wellness/Fitness | Clinical trial |
|---|---|---|
| Use case | User: healthy middle-aged adult engaging in employee wellness programme in a large multinational organisation | User: volunteer participant in clinical trial |
| Provider: employer/health Insurer | Provider: Clinical Trial Organisation | |
| Goal: monitor activity, sleep, mood and nutrition during a healthy lifestyle promotion initiative. Primary goal is to provide summary and trend reports back to employees to motivate them during programme. | Goal: monitor participant’s activity and sleep during study to provide for accurate measurement of impact of therapeutic intervention. | |
| Device requirements | • Unobtrusive, with deploy and forget capability • Flexible body location • Measurement accuracy desirable, yet not critical • Battery life: >3 months preferable • Automated synchronisation with user’s own data aggregation & communication device (e.g., smartphone) • Automated upload to server. | • Unobtrusive, with deploy and forget capability • Wrist worn location • Validated measurement accuracy, supported by regulatory filing • Battery life: >1 week • Automated synchronisation with provisioned data aggregator • Automated upload to server. |
Fig. 1Evaluation framework’s three-step process
Excerpt from the Requirements Definition template
| Requirement | Description | Answer |
|---|---|---|
| Timeframe | Consider the service/study start date, duration and its conclusion (if applicable). | |
| Solution description and requirements | Provide a description of the solution required. Consider what you want to achieve with the solution and any specific features or capabilities required. | |
| Data requirements | Provide a description of the data requirements. Consider what data needs to be collected via the solution. |
Example of comparison matrix in practice
| Essential requirements | Device 1 | Device 2 | Device 3 | Device 4 |
|---|---|---|---|---|
| Wrist worn device | ✓ | ✓ | ✓ | X |
| Battery life >1 week | ✓ | ✓ | ✓ | ✓ |
| iOS and Android compatible | ✓ | ✓ | ✓ | ✓ |
| FDA approved | X | ✓ | ✓ | X |
Excerpt from the device evaluation template
| Technical evaluation | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Component | Query | Device 1 | Device 2 | Device 3 | Device 4 | Requirement fulfilled? Y/N/NA/Not clear | |||
| Device 1 | Device 2 | Device 3 | Device 4 | ||||||
| Device specification | (A) What are the device dimensions? | ||||||||
| (B) What is the device weight? | |||||||||
| (C) What is the device lifespan? | |||||||||
| Variable measured | (A) What is the target measurement variable? | ||||||||
| (B) What other variables can be measured? | |||||||||
| (C) What instruments are in the device (e.g., accelerometer, gyroscope, stress gauge, etc.)? | |||||||||
| Connectivity | (A) E.g. wired, BT, BTLE, Zigbee, Wi-Fi, serial connection? | ||||||||
Fig. 2Main project stages and stakeholder input
Application requirements
| Requirement | Description |
|---|---|
| Application purpose | This medication adherence service will aim at assisting targeted patient populations remain compliant with medication regimens. |
| As a first step, the service provider will conduct a pilot study to better understand the impact of smart pill adherence tracking devices on medication compliance levels. The following questions will be addressed: | |
1. What are the relevant adherence rates among the 3 study arms: (a) patient uses no device (e.g., conventional plastic bottle/manual adherence tracking); (b) patient uses a pill adherence tracking device without any associated follow-up intervention in the event of non-adherence; and (c) patient uses a pill adherence tracking device with a follow-up intervention in the event of non-adherence. 2. What are the (a) usability and (b) technical/ installation/operational issues associated with the chosen pill adherence tracking device in a home setting? | |
| Cohort profile | Hypertension patients >65 years taking tablets 1x / day. |
| Total number of patients across the 3 groups yet to be defined. | |
| Ethnographic analysis | Given that hypertension patients are typically 60 years or older, factors related to ageing would have to be considered (i.e. poorer levels of sight, hearing, and dexterity through the fingers) and will inform decisions regarding device selection. |
| Setting | Home |
| Geographical location | Dublin, Ireland |
| Timeframe | 6 Months |
| Deployment duration | Patients will be asked to track their medication adherence for 2 months. |
| What data need to be collected (via device)? | Electronic Medication Compliance Data (timestamp). |
| What type of device is required? | Smart pill adherence tracking device. |
| What level of accuracy is required? | Medical standard device—device classification (e.g., class I, class II) to be determined as part of the device evaluation process. |
| Are there any ethical issues to be considered? | None of significance |
| Standards and regulatory factors to be considered | Compliant with EU standards (CE marking and EU Data Protection Directive). |
| Hygiene considerations | Devices used require cleaning on return. |
| Human factors to be considered | Patient: ease of use, reliability, durability. |
| Service provision: ease of installation. | |
| Device: must be portable (e.g., on vacation) and allow offline use. | |
| Technical factors to be considered | Device manufacturer must provide a mechanism for the data to be pulled from their servers (this will allow the service provider to use their own application instead of manufacturer’s app). |
| Must allow real-time access to monitoring data by other services. | |
| Must provide an optional follow-up intervention in the event of non-adherence (group (b): won’t use this feature; group (c): will). | |
| Budget | To be determined as part of the device evaluation process. |
| In-house expertise available | Design and engineering staff |
Device shortlisting
| Core requirements | eCap | GlowCap | Dosecue | iMPack Health Kraken | LineHealth | MedFolio | MEMSCap | Philips Medication Dispensing Service | MedSmart PLUS | AdhereTech | Med-e-lert | Med Signals | SMRxT | uBox | Wisepill |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smart or connected device | Yes | Yes (via AT&T Cellular Network) | Yes | Yes | Yes | Yes | Not clear | Connected to remote monitoring service | Connected to remote monitoring service | Yes | No | Yes | Yes | Yes | Yes |
| Ability to track medication (pill/tablet) adherence | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No timestamp recorded | Yes | Yes | Yes | Yes |
| Portable device | Yes | Yes + plugged into power outlet | Yes | Yes | Yes | Yes | Yes | No | Yes, but must be connected to phone line to send data | Yes | Yes | Yes | Yes | Yes | Yes |
| Offline use enabled (store + forward) | Yes | Not clear | Not clear | Yes | Not clear | No | Yes | No | Yes | Yes | No | Yes | Not clear | Not clear | Yes |
| Ability of other services to access monitoring data (near) real time | Not clear | Yes | Yes | Not clear | Yes | Yes | Not clear | No | No | Yes | Not clear | Yes | Not clear | Not clear | Yes |
| Currently available for purchase | Not clear | Yes | Not clear | Not clear | Not clear | Not clear | Not clear | Yes | Yes | Yes | No | Yes | Not clear | No | Yes |
| Distributed in Ireland | Not clear | Not clear | Not clear | Not clear | Not clear | Not clear | Not clear | No | No | Yes | No | Yes | No | No | Yes |
| Compliance with EU regulations | Not clear | Not clear | Not clear | Research purpose only | No | Not clear | Not clear | Not clear | No | Yes | Not clear | Yes | No | Not clear | Yes |